Trending topics and news in HCT and Cellular Therapy

Topics to Explore

Tandem Meetings News

Published on February 15, 2025

Session examines post-HCT relapse in AML

Vanessa Kennedy, MD, and other experts detailed novel targets, next-gen transplantation techniques and more.

RELATED NEWS

GVHD

Low rates of chronic graft-versus-host disease with ruxolitinib maintenance following allogeneic HCT

by Alex Kadhim

Researchers from Massachusetts General Hospital and collaborating institutions conducted a prospective, multicenter phase II clinical trial demonstrating that prolonged administration of...

GVHD

High Melphalan Exposure Increases the Risk of Graft-versus-Host Disease in Pediatric Patients Undergoing Alpha-Beta T-Cell Depleted Haploidentical Transplantation

by Alex Kadhim

In a recent study, researchers from the University of California, San Francisco, have demonstrated that high exposure to melphalan significantly increases the risk of graft-versus-host disease...